1. Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2
   Lu-ming Wang et al, 2024, Chinese Journal of Integrative Medicine CrossRef
2. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation
   Cheng Zhang et al, 2018, Cardiovascular Research CrossRef
3. Effect of dipyridamole on myocardial reperfusion injury: A double‐blind randomized controlled trial in patients undergoing elective coronary artery bypass surgery
   S El Messaoudi et al, 2016, Clinical Pharmacology & Therapeutics CrossRef
4. RNA Interference of Myocyte Enhancer Factor 2A Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice
   Wen-ping Zhou et al, 2015, PLOS ONE CrossRef
5. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A2 and YKL-40
   Hui Zhang et al, 2018, PLOS ONE CrossRef
6. Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
   Hui Zhang et al, 2019, Scientific Reports CrossRef
7. Role of Lipoprotein-Associated Phospholipase A2 in Vascular Disease
   Robert S. Rosenson et al, 2015, Clinical Lipidology CrossRef